Status:
RECRUITING
Modeling of Intracerebral Vascularization After Extracorporeal Membrane Oxygenation in Children
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Extra Corporeal Membrane Oxygenation
Decanulated Alive
Eligibility:
All Genders
Up to 17 years
Brief Summary
Extra corporeal membrane oxygenation (ECMO) is a transient supplementation technique that alleviates hemodynamic and ventilatory failure. Its implementation requires carotid arterial and jugular venou...
Detailed Description
Extra corporeal membrane oxygenation (ECMO) is a transient supplementation technique that alleviates hemodynamic and ventilatory failure. Its implementation requires carotid arterial and jugular venou...
Eligibility Criteria
Inclusion
- For everyone :
- Information and non-opposition of holders of parental authority
- Newborn, infant and child \<20kg
- Hospitalization in pediatric and neonatal intensive care unit (PICU) of Trousseau Hospital
- Performing a Magnetic Resonance Angiography (MRA) as part of the treatment
- For patients treated with ECMO: study population
- Hemodynamic or respiratory failure
- Requiring the use of extracorporeal circulation with jugulo-carotid cannulation
- Weaned alive off Extra corporeal membrane oxygenation (ECMO)
- For patients with hypoxic-ischemic encephalopathy: control population
- hypoxic-ischemic encephalopathy diagnosed at birth
Exclusion
- Contraindication to MRA
- Opposition of holders of parental authority
Key Trial Info
Start Date :
March 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05237232
Start Date
March 31 2022
End Date
August 1 2026
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Trousseau
Paris, France, 75012